Factors leading to low prevalence of DVT and pulmonary embolism after THA: Analysis of genetic and prothrombotic factors

Clinical Orthopaedics and Related Research

Volumn 465, Issue , 2007, Pages 33-39

  Kim, Young Hoo ^a,b   Kim, Jun Shik ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; AGED; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD GROUP TYPING; CONFERENCE PAPER; CONFIDENCE INTERVAL; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRAIT; HUMAN; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RADIOGRAPHY; RISK FACTOR; STATISTICAL SIGNIFICANCE; TOTAL HIP PROSTHESIS; ARTICLE; AWARDS AND PRIZES; BLOOD; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; HIP ARTHROPLASTY; KOREA; MIDDLE AGED; PATHOLOGY; PROMOTER REGION; RISK ASSESSMENT; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN III; ARTHROPLASTY, REPLACEMENT, HIP; AWARDS AND PRIZES; BLOOD COAGULATION; FACTOR V; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KOREA; MALE; MIDDLE AGED; PHLEBOGRAPHY; PREVALENCE; PROMOTER REGIONS (GENETICS); PROTHROMBIN; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 37349036920     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e318156bfac     Document Type: Conference Paper

References (47)

1. Atik M, Harkess JW, Wichman H. Prevention of fatal pulmonary embolism. Surg Gynecol Obstet. 1970;130:403-413.
2. Balasa VV, Gruppo RA, Glueck CJ, Stroop D, Becker A, Pillow A, Wang P. The relationship of mutations in the MTHR prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost. 1999;81:739-744.
3. Chau KY, Yuen ST, Wong SP. Clinicopathological pattern of pulmonary thromboembolism in Chinese autopsy patients: comparison with Caucasian series. Pathology. 1997;9:263-266.
4. Chumnijarakij T, Poshyachinda V. Postoperative thrombosis in Thai women. Lancet. 1975;1:1357-1358.
5. Clarke MT, Green JS, Harper WM, Gregg PJ. Screening for deep venous thrombosis after hip and knee replacement without prophylaxis. J Bone Joint Surg Br. 1997;79:787-791.
6. Coventry MB, Nolan DR, Beckenbaugh RD. "Delayed" prophylactic anticoagulation: a study of results and complications in 2012 total hip arthroplasties. J Bone Joint Surg Am. 1973;55:1487-1492.
7. Doouss TW. The clinical significance of venous thrombosis of the calf. Br J Surg. 1976;63:377-378.
8. Evarts CM, Feil EJ. Prevention of thromboembolic disease after elective surgery of the hip. J Bone Joint Surg Am. 1971;53:1271-1280.
9. Fender D, Harper WM, Thompson JR, Gregg PJ. Mortality and fatal pulmonary embolism after primary total hip replacement. Results from a regional hip register. J Bone Joint Surg Br. 1997;78:896-899.
10. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Welliams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 2000;82:929-938.
11. Giachino A. Relationship between deep-vein thrombosis in the calf and fatal pulmonary embolism. Can J Surg. 1988;31:129-130.
12. Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Weksler BB, Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol. 2001;97:44-48.
13. Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, DeSanctis RW. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med. 1977;297:1246-1249.
14. Horn JS, Wang YC. The mechanism, traumatic anatomy and nonoperative treatment of intertrochanteric fracture of the femur. Br J Surg. 1964;51:574-580.
15. Kakkar VV, Howe CT, Flanc C, Clark MB. Natural history of postoperative deep vein thrombosis. Lancet. 1969;2:230-232.
16. Kim Y-H. The incidence of deep vein thrombosis after cementless and cemented knee replacement. J Bone Joint Surg Br. 1990;72:779-783.
17. Kim Y-H, Kim J-S. Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomized study. J Bone Joint Surg Br. 2002;84:566-570.
18. Kim Y-H, Kim VEM. Factors leading to low incidence of deep vein thrombosis after cementless and cemented total knee arthroplasty. Clin Orthop Relat Res. 1991;273:119-124.
19. Kim Y-H, Oh S-H, Kim J-S. Incidence and natural history of deepvein thrombosis after total hip arthroplasty. A prospective and randomized clinical study. J Bone Joint Surg Br. 2003;85:661-665.
20. Kim Y-H, Suh J-S. Low incidence of deep vein thrombosis after cementless total hip replacement. J Bone Joint Surg Am. 1988;70:878-882.
21. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-American. Am J Cardiol. 2000;85:1334-1337.
22. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9-13.
23. Lieberman JR, Wollaeger J, Dorey F, Thomas BJ, Kilgus DJ, Grecula MJ, Finerman GA, Amstutz HC. The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty. J Bone Joint Surg Am. 1997;79:319-325.
24. Lotke PA, Steinberg ME, Ecker ML. Significance of deep venous thrombosis in the lower extremity after total joint arthroplasty. Clin Orthop Relat Res. 1994;299:25-30.
25. Morris GK, Henry AP, Preston BJ. Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. Lancet. 1974;2:797-799.
26. Moser KM, LeMoine R. Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med. 1981;94:439-444.
27. Murray DW, Britton AK, Bulstrode CJ. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg Br. 1996;78:863-870.
28. Murray DW, Carr AJ, Bulstrode CJK. Pharmacological thromboprophylaxis after hip and knee replacement without prophylaxis. J Bone Joint Surg Br. 1995;77:3-5.
29. Nandi P, Wong KP, Wei WI, Ngan H, Ong GB. Incidence of postoperative deep vein thrombosis in Hong Kong Chinese. Br J Surg. 1980;67:251-253.
30. Paiement GD, Wessinger SJ, Hughes R, Harris WH. Routine use of adjusted low-dose warfarin to prevent venous thromboembolism after total hip replacement. J Bone Joint Surg Am. 1993;75:893-898.
31. Patterson BM, Marchand R, Ranawat C. Complications of heparin therapy after total joint arthroplasty. J Bone Joint Surg Am. 1989;71:1130-1134.
32. Pellegrini VD, Langhans MJ, Tottermans S, Marder VJ, Francis CW. Embolic complications of calf thrombosis following total hip arthroplasty. J Arthroplasty. 1993;8:449-457.
33. Pellegrini VD Jr, Clement D, Lush-Ehmann C, Keller GS, Evarts CM. The John Charnley Award. Natural history of thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 1996;333:27-40.
34. Price DT, Ridker PM. Factor V Leiden mutation and the risk for thromboembolic disease: a clinical perspective. Ann Intern Med. 1997;127:895-903.
35. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133-1134.
36. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 1997;277:1305-1307.
37. Rosner B. Fundamentals of Biostatics, 5th ed. Pacific Grove, CA: Duxbury; 2000:527-530.
38. Salzman EW, Harris WH, DeSanctis RW. Reduction in venous thromboembolism by agents affecting platelet function. N Engl J Med. 1971;284:1287-1292.
39. Thomas DP, Roberts HR. Hypercoagulability in venous and arterial thrombosis. Ann Intern Med. 1997;126:638-644.
40. THRIFT. Thromboembolic Risk Factors Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ. 1992;305:567-574.
41. Tinckler LF. Absence of pulmonary embolism in Asians? BMJ. 1964;1:502.
42. Tso SC, Wong V, Chan V, Chan TK, Ma HK, Todd D. Deep vein thrombosis and changes in coagulation and fibrinolysis after gynaecological operations in Chinese: the effect of oral contraceptives and malignant disease. Br J Haematol. 1980;46:603-612.
43. Warwick D, Williams MH, Bannister GC. Death and thromboembolic disease after total hip replacement: a series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg Br. 1995;77:6-10.
44. Westrich GH, Farrell C, Bono JV, Ranawat CS, Salvati EA, Sculco TP. The incidence of venous thromboembolism after total hip arthroplasty: a specific hypotensive epidural anesthesia protocol. J Arthroplasty. 1999;14:456-463.
45. Westrich GH, Weksler BB, Glueck CJ, Blumenthal BF, Salvati EA. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty. An analysis of genetic factors. J Bone Joint Surg Am. 2002;84:2161-2167.
46. Woo KS, Tse LK, Tse CY, Metreweli C, Vallance-Owen J. The prevalence and pattern of pulmonary thromboembolism in the Chinese in Hong Kong. Int J Cardiol. 1988;20:373-380.
47. Zivelin A, Rosenberg N, Faier S, Kornbrot N, Peretz H, Manhalter C, Horellou MH, Seligsohn U. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood. 1998;92:1119-1124.